|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.996
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.779
|
Human Mouse |
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.769
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.751
|
Human Mouse |
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.725
|
Human Mouse |
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.723
|
Human Mouse |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.648
|
Human Mouse |
|
|
actin filament organization
|
GO:0007015 |
113 |
0.614
|
Human Mouse |
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.573
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.537
|
Human Mouse |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.537
|
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.508
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.424
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.421
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.419
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.413
|
Human |
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.409
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.379
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.312
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.306
|
Human Mouse |
|
|
positive regulation of actin filament depolymerization
|
GO:0030836 |
5 |
0.295
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.293
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.293
|
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.286
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.280
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.271
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.261
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.254
|
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
13 |
0.248
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.246
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.230
|
Human |
|
|
tube formation
|
GO:0035148 |
140 |
0.230
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.226
|
Human Mouse |
|
|
regionalization
|
GO:0003002 |
337 |
0.225
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.223
|
Human Mouse |
|
|
heart contraction
|
GO:0060047 |
93 |
0.213
|
|
|
|
positive regulation of protein complex disassembly
|
GO:0043243 |
5 |
0.211
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.210
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.209
|
Human Mouse |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.199
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.195
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.186
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.185
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.184
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.182
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.175
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.175
|
Human Mouse |
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.173
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.171
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.168
|
Human Mouse |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.167
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.162
|
Human |
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.162
|
Human Mouse |
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.158
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.154
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.153
|
Human Mouse |
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.152
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.148
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.147
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.146
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.142
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.141
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.141
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.140
|
Human |
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.138
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.136
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.135
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.132
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.130
|
Human |
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.123
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.122
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.119
|
|
|
|
regulation of dendritic spine morphogenesis
|
GO:0061001 |
17 |
0.117
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.116
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.114
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.113
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.109
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.109
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.108
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.107
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.107
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.106
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.105
|
Human |
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.105
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.104
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.103
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.102
|
Human Mouse |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.102
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.100
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.099
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.095
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.093
|
Human |
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.090
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.089
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.089
|
Human Mouse |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.088
|
Human |
|
|
negative regulation of actin filament polymerization
|
GO:0030837 |
11 |
0.087
|
Human Mouse |
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.086
|
Mouse |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.085
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.085
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.084
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.083
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.083
|
|
|
|
negative regulation of purine nucleotide catabolic process
|
GO:0033122 |
9 |
0.082
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.081
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.081
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.081
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.081
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.081
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.081
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.080
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.080
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.077
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.077
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.077
|
Human |
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.076
|
Human Mouse |
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.075
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.075
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.073
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.073
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.073
|
Human |
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.073
|
Human Mouse |
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.072
|
Human |
|
|
gonad development
|
GO:0008406 |
141 |
0.072
|
|
|
|
barbed end actin filament capping
|
GO:0051016 |
6 |
0.072
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.070
|
Human |
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.068
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.068
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.068
|
Human Mouse |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.067
|
Human |
|
|
chromatin modification
|
GO:0016568 |
187 |
0.067
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.065
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.063
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.063
|
Human Mouse |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.063
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.063
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.063
|
Human Mouse |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.062
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.062
|
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.062
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.062
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.061
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.061
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.060
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.060
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.059
|
Human Mouse |
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.059
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.059
|
Human Mouse |
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.059
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.059
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.058
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.058
|
Human |
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.057
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.057
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.057
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.056
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.056
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.056
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.056
|
Human Mouse |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.056
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.055
|
|
|
|
negative regulation of nucleoside metabolic process
|
GO:0045978 |
11 |
0.055
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.054
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.054
|
Human |
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.053
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.052
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.052
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.051
|
Human |
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.051
|
Human Mouse |
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.050
|
Human Mouse |
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.050
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.050
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.050
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.049
|
Mouse |
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.049
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.049
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.049
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.048
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.048
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.048
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.047
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.047
|
|
|
|
poly a mrna export from nucleus
|
GO:0016973 |
4 |
0.047
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.047
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.046
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.046
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.045
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.045
|
Human |
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.045
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.045
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.044
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.044
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.044
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.044
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.044
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.044
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.044
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.044
|
Human |
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.043
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.043
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.043
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.043
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.043
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.043
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.043
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.043
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.042
|
Human |
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.042
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.042
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.042
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.041
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.041
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.041
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.041
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.040
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.040
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.040
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.040
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.040
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.040
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.040
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.039
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.038
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.038
|
Mouse |
|
|
gliogenesis
|
GO:0042063 |
141 |
0.038
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.037
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.037
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.037
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.037
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.036
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
Mouse |
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.036
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.035
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.035
|
Human |
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.035
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.035
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.035
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.035
|
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.034
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.034
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.034
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.033
|
|
|
|
actin filament capping
|
GO:0051693 |
6 |
0.033
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.032
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.032
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.032
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.032
|
Human |
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.032
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.032
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.032
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.032
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.031
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.031
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.031
|
Human |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.031
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.031
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.031
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.031
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.030
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.030
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.030
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.030
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.030
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.030
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.030
|
|
|
|
translation
|
GO:0006412 |
93 |
0.029
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.029
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.029
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.029
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.029
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.029
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.029
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.028
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.028
|
Human |
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.028
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.028
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.028
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.028
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.028
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.028
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.028
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.028
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.027
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.027
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.027
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.027
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.027
|
Human Mouse |
|
|
muscle system process
|
GO:0003012 |
141 |
0.027
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.027
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.027
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.026
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.026
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.026
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.026
|
|
|
|
regulation of protein heterodimerization activity
|
GO:0043497 |
2 |
0.026
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.026
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.026
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.026
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
Human |
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.025
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.025
|
Mouse |
|
|
cellularization
|
GO:0007349 |
1 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
Human |
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.025
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.025
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.025
|
|
|
|
regulation of dendritic spine development
|
GO:0060998 |
22 |
0.025
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.024
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.024
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.024
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.024
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.024
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.024
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.024
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.024
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.023
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.023
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.023
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.023
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.023
|
Mouse |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.023
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.023
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.022
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.022
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.022
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.022
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
Human |
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.022
|
Mouse |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.022
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.022
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.022
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.022
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.021
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.021
|
|
|
|
positive regulation of protein depolymerization
|
GO:1901881 |
5 |
0.021
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.021
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.021
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.021
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.021
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.021
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.021
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.020
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.020
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.020
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
Human |
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.020
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.020
|
|
|
|
mating
|
GO:0007618 |
27 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.019
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.019
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
|
negative regulation of atpase activity
|
GO:0032780 |
2 |
0.019
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.019
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.019
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.019
|
Mouse |
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.019
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.019
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.019
|
Human Mouse |
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.019
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.019
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.019
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
Human Mouse |
|
|
cleavage furrow formation
|
GO:0036089 |
2 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.018
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.018
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.018
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.018
|
|
|
|
uropod organization
|
GO:0032796 |
2 |
0.018
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.018
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.018
|
Mouse |
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.017
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.017
|
Human |
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.017
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
Human |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
Human |
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.017
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.017
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
|
negative regulation of nucleotide metabolic process
|
GO:0045980 |
16 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.017
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.017
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.017
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.017
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
Human |
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.016
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.016
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.016
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.016
|
Human |
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.016
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.016
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.016
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.016
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.016
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
regulation of hematopoietic stem cell differentiation
|
GO:1902036 |
1 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.016
|
|
|
|
mating behavior
|
GO:0007617 |
20 |
0.016
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.015
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.015
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.015
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.015
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.015
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.015
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.015
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.015
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.015
|
Mouse |
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.015
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.015
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.015
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.014
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.014
|
Mouse |
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.014
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.014
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.014
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.014
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.014
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.014
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.014
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.014
|
|
